News

New tools for cancer research: Plasminogen Activation System antibodies May 05 2008

Product launch - Anti-NGAL (monkey) antibody April 10 2008

The Biomarker World Congress 2008, 19-21 May - Philadelphia, USA April 10 2008

ISICEM, Brussels, Belgium 18-21 March 2008 March 04 2008

BioPorto at ToxExpo, Seattle, Washington 16-20 March 2008 February 13 2008

We are participating at Arab Health Congress the 28 - 31 Jan 2008 in Dubai January 17 2008

AntibodyShop is now BioPorto Diagnostics! December 28 2007

2008 Product catalog available December 28 2007

Launch www.NGAL.com November 01 2007

L- and M-Ficolin antibodies launched October 22 2007

next 10

Product launch - Anti-NGAL (monkey) antibody

April 10 2008 by Janus Guttesen

BioPorto Diagnostics is pleased to announce the release of a new anti-monkey NGAL monoclonal antibody for sale. The antibody is expected to find use in the area of pre-clinical studies and acute kidney injury research.

The new monoclonal antibody (ABS 038-23) is specific for the monkey NGAL and is selected specifically for the ability to form an ELISA sandwich pair with biotinylated HYB 211-02 as detection antibody.

The antibody pair is for research use only and can be used to assay early nephrotoxicity of pharmacological compound in monkeys on an ELISA platform.

With the launch of monkey NGAL antibodies, BioPorto Diagnostics NGAL portfolio now consists of ELISA kits and antibodies against human, rat and monkey NGAL. Our NGAL portfolio will be expanded with mouse, dog, and pig antibodies in the near future.